Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Rheacell GmbH & Co. Kg has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 3 distinct examiners and 3 distinct art units. This arrangement indicates that each of the 3 pending matters is being reviewed in a separate technical and personnel environment, ensuring that no single examiner dominates the company's current prosecution activity.
GORDON, BRIAN R is the busiest examiner for this portfolio. This examiner is managing 1 pending office action, while the other pending actions are handled by different examiners. With the 3 pending office actions split equally among the distinct examiners, practitioners must develop individualized strategies for each case. The lack of overlap between the 3 distinct art units means that the prosecution of each application will likely be influenced by the specific departmental standards and examiner preferences unique to each matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GORDON, BRIAN R | 1 | 65.3% | +19.0% |
| BEHARRY, ZANNA MARIA | 1 | 25.0% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18699716 | ABCB5 STEM CELL PROCESSING | GORDON, BRIAN R | — |
| 17915364 | USE OF STEM CELLS FOR TREATMENT OF EXCESSIVE INFLAMMATION | BEHARRY, ZANNA MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18699716 | ABCB5 STEM CELL PROCESSING | GORDON, BRIAN R | — |
| 17915364 | USE OF STEM CELLS FOR TREATMENT OF EXCESSIVE INFLAMMATION | BEHARRY, ZANNA MARIA | — |
| Art Unit | Apps |
|---|---|
| 1798 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18699716 | ABCB5 STEM CELL PROCESSING | GORDON, BRIAN R | 1798 | §102§103§112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 17915364 | USE OF STEM CELLS FOR TREATMENT OF EXCESSIVE INFLAMMATION | BEHARRY, ZANNA MARIA | 1632 | §112 | Non-Final OA | — | Pending | Sep 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRheacell GmbH & Co. Kg has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Brian R Gordon has the most, with 1 of Rheacell GmbH & Co. Kg's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
